A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

NCT07668336 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Orforglipron
DRUG: Dulaglutide

Sponsor

Eli Lilly and Company